Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
India
· Delayed Price · Currency is INR | Market Cap | 4.28T |
| Revenue (ttm) | 568.09B |
| Net Income (ttm) | 109.15B |
| Shares Out | 2.40B |
| EPS (ttm) | 45.45 |
| PE Ratio | 39.26 |
| Forward PE | 35.05 |
| Dividend | 16.00 (0.90%) |
| Ex-Dividend Date | Feb 5, 2026 |
| Volume | 3,669,921 |
| Average Volume | 2,076,852 |
| Open | 1,784.50 |
| Previous Close | 1,784.50 |
| Day's Range | 1,771.80 - 1,805.60 |
| 52-Week Range | 1,548.00 - 1,851.20 |
| Beta | 0.12 |
| RSI | 64.17 |
| Earnings Date | May 22, 2026 |
About NSE:SUNPHARMA
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including neuropsychiatry, cardiology, diabetes, gastroenterology, pain/analgesics, gynecology, ophthalmology, urology, dermatology, respiratory, anti-infectives, oncology, psychiatry, neurology, orthopaedic, nephrology, urology, dermatology, respira... [Read more]
Financial Performance
In fiscal year 2025, NSE:SUNPHARMA's revenue was 525.78 billion, an increase of 8.42% compared to the previous year's 484.97 billion. Earnings were 109.29 billion, an increase of 14.12%.
Financial StatementsNews
Nifty 50 top gainers today, March 2: Bharat Electronics, Hindalco Industries, Sun Pharma, ONGC and more
Indian equity benchmarks closed lower on March 2, with the Nifty 50 ending at 24,865.70, down 312.95 points or 1.24%....
UPDATE: Fortress Biotech's Subsidiary Cyprium Therapeutics Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $205 Million
MIAMI, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) ("Fortress") and its majority-owned subsidiary, Cyprium Therapeutics, Inc. ("Cyprium"), today announced that Cyprium ent...
Fortress Biotech's Subsidiary Cyprium Therapeutics Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $205 Million
MIAMI, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) ("Fortress") and its majority-owned subsidiary, Cyprium Therapeutics, Inc. ("Cyprium"), today announced that Cyprium ent...
Speeding SUV kills food delivery agent on Sun Pharma Road
Vadodara: A food delivery worker died in a road accident after he was run over by an SUV on Sun Pharma Road in the city in the early hours of Saturday.
India-US trade deal clarity: Pharma exporters gain edge in US; sector eyes growth boost
Indian drugmakers anticipate significant benefits from the proposed India-US trade agreement, offering much-needed clarity and stability for the lucrative US pharmaceutical market. This development is...
Sun Pharma receives FDA Rare Pediatric Disease Priority Review Voucher for Sezaby
Sun Pharma Advanced Research Company Ltd. (SPARC) announced that the United States Food and Drug Administration (FDA) has granted a...
Sun Pharmaceuticals Industries Ltd (BOM:524715) Q3 2026 Earnings Call Highlights: Strong Sales ...
Sun Pharmaceuticals Industries Ltd (BOM:524715) Q3 2026 Earnings Call Highlights: Strong Sales Growth and Strategic Challenges
Q3 2026 Sun Pharmaceutical Industries Ltd Earnings Call Transcript
Q3 2026 Sun Pharmaceutical Industries Ltd Earnings Call Transcript
Pharma sector stocks today, Feb 1: Shilpa Medicare rally 8%, Sun Pharma up 3%, Aurobindo Pharma falls 2.21%
The Indian pharmaceutical sector showed mixed performance as of February 1, 2026, around 10 AM IST, with many stocks trading...
Sun Pharma shares jump over 3% as revenue rises 13.5% YoY to Rs 15,469.1 crore, net profit up 16%
Shares of Sun Pharmaceutical Industries Limited surged more than 3% after the company reported robust consolidated financial results for the...
Sun Pharma board declares interim dividend of Rs 11 per share for FY26
Sun Pharmaceutical Industries Limited announced an interim dividend of ₹11.00 per equity share for the financial year FY26 following the...
Sun Pharma Q3 Results: Revenue jumps 15.1% YoY to Rs 15,469.1 crore, net profit up 16%
Sun Pharmaceutical Industries Limited reported its consolidated financial results for the third quarter ended December 31, 2025. The results were...
Top Q3 results today, January 31: IDFC First Bank, GAIL, Delhivery, Bharat Dynamics, Sun Pharma and more to announce earnings
More than 75 listed companies are scheduled to announce their Q3FY26 financial results today, January 31, making it one of...
Pharma sector stocks today, Jan 28: RPG Life falls 8.88%, Sun Pharma down 1.14%, Morepen Labs up to 2.98%
The Indian pharmaceutical sector showed mixed performance on January 28, 2026, as of around 10:13 AM IST. Broader market indices...
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Dru...
Sun Pharma Gains Approval for Generic Wegovy in India
Sun Pharma Gains Approval for Generic Wegovy in India
Sun Pharma cleared to sell generic Wegovy, intensifying India’s obesity-drug race with Novo Nordisk
Sun Pharma gets DCGI nod to manufacture and market generic semaglutide injection in India
Sun Pharmaceutical Industries Limited has received approval from the Drugs Controller General of India (DCGI) to manufacture and market a...
Pharma sector stocks today: Senores up 1.79%, Lupin rises 1%, Sun Pharma jumps 0.81%,
The Indian pharma sector stocks showed mixed performance as of 10:22 AM IST on January 21, 2026. Broader market context...
Sun Pharma Eyes Organon In What Could Be India Pharma's Biggest Cross-Border Deal: Report
India-based Sun Pharmaceutical Industries Ltd is reportedly evaluating a potential acquisition of Organon & Co (NYSE: OGN), a U.S.-based women's healthcare company. If it goes through, the deal that ...
Organon (OGN) Shares Surge on Acquisition Offer from Sun Pharma
Organon (OGN) Shares Surge on Acquisition Offer from Sun Pharma
Organon gains on report of Sun Pharmaceutical interest
Pharma sector stocks fall today: Glenmark Pharma drops 1.38%, Aurobindo Pharma downm 1.25%, Sun Pharma falls 0.87, Dr. Reddy’s Lab down 0.48%
The pharma sector stocks in India experienced declines as of 10 AM on January 20, 2026, aligning with broader market...
Pharma sector stocks today: Sun Pharma falls 1.43%, Ipca Labs down 1.32%, Alembic Pharma drops 1.08%
The Indian pharmaceutical sector showed mixed performance on January 16, 2026, as of around 10 AM IST. Broader market indices...
Top stocks to watch today, January 16: Infosys, Sun Pharma, BHEL, ICICI Prudential, HDFC Life and more
Indian equity benchmark indices are likely to open on a flat note on Friday, tracking mixed global cues and subdued...